CRBP Overview
Upcoming Projects (CRBP)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (CRBP)
-
Discussing the potential of INV-202 (Monlunabant), a CB1 antagonist currently in development by Novo Nordisk for weight loss
Tickers: NVO, LLY, CRBP
Executed On: Aug 20, 2024 at 10:30 AM EDT -
Discussing the CB1 axis to treat obesity, including CBR-913 and nimicimab
Tickers: CRBP, SKYE, NVO
Executed On: May 06, 2024 at 03:00 PM EDT
Upcoming & Overdue Catalysts (CRBP)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (CRBP)
-
Corbus Pharma (CRBP) Releases Phase 2 Results Evaluating Resunab in Diffuse Cutaneous Systemic Sclerosis
Ticker: CRBP
Occurred on: Nov 14, 2016 -
Corbus Pharmaceuticals Expands Clinical Development of Resunab With Phase 2 Trial for the Treatment of Systemic Lupus Erythematosus
Ticker: CRBP
Occurred on: Mar 07, 2016
Strategic Initiatives (CRBP)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
